MORPHOLOGICAL PARALLELS OF THE STRUCTURE OF VESSEL’S WALL AT VARICOSE EXTENSION OF THE VEINS OF PELVIS AND LOWER EXTREMITIES

The histological differences in the structure of the ovarian vein and saphenous veins of the lower extremities during their varicose transformation have been insufficiently studied in the modern literature. The study aims to determine the morphological parallels of the structure of varicose veins in varicose veins of the pelvis and varicose veins of the lower extremities. Fifty histological biopsy specimens of removed veins were examined in women. Of these, 25 large saphenous veins were obtained from patients with varicose veins of the lower extremities and 25 preparations of a resected ovarian vein from 25 women with varicose veins of the pelvis. The preparation was stained with hematoxylin-eosin and by the Van Gieson method, studied by light microscopy. In the study of the preparations, significant structural changes were noted in all layers of the venous wall, both in varicose veins of the pelvis and in varicose veins of the lower extremities in the form of a combination of atrophic, fibroplastic and hypertrophic processes leading to the loss of its functional properties. Depending on the decompensation of pathological processes, 3 morphological forms of lesions of the venous wall structure were revealed. The hypertrophic form was found in 17 (34%) surgery perform women, fibrous - in 13 (26%), atrophic - in 20 (40%). In the group of patients with varicose veins of the pelvis compared with the group of patients with varicose veins of the lower extremities, the prevalence of initial forms of lesion was revealed. There was a correlation between the severity of venous vascular lesions with the duration of the disease and the patient's age, the number of risk predictors and a high body mass index, which was the determining factor in the occurrence of this phenomenon. The results of this study indicate the similarity of the pathological picture of venous lesions, both in varicose veins of the pelvis and in varicose veins of the lower extremities.

1. Rabe E, Puskas A, Scuderi A, Fernandez QF, VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol. 2012;31(2):105-115.

2. Lohr JM, Bush RL. Venous disease in women: epidemiology, manifestations, and treatment. J Vasc Surg. 2013;57(4):37S-45S. DOI:10.1016/j.jvs.2012.10.121.

3. Howard FM. Chronic pelvic pain. Obstetrics Gynecology. 2003;101:594–611. DOI:10.1016/S0029-7844(02)02723-0.

4. Steenbeek MP, van der Vleuten CJM, Schultze KLJ, Nieboer TE. Noninvasive diagnostic tools for pelvic congestion syndrome: a systematic review. Acta Obstet Gynecol Scand. 2018;97(7):776–786. DOI:10.1111/aogs.13311.

5. Ganeshan A, Upponi S, Hon LQ, Uthappa MC, Warakaulle DR, Uberoi R. Chronic pelvic pain due to pelvic congestion syndrome: The role of diagnostic and interventional radiology. Cardiovasc Intervent Radiol. 2007;30:1105–1111.

6. Belenky A, Bartal G, Atar E, Cohen M., Bachar G.N. Ovarian varices in healthy female kidney donors: incidence, morbidity, and clinical outcome. AJR Am J Roentgenol 2002;179:625–627.

7. Gupta R, Gupta A, Aggarwal N. Variations of gonadal veins: embryological prospective and clinical significance. J Clin Diagn Res. 2015;9(2):AC08–10. DOI: 10.7860/JCDR/2015/9493.5578.

8. Tsukanov YuT, Tsukanov AYu, Shcheglov AYu, Mozgovoy SI. Patomorfologiche-skie aspekty varikoznogo porazheniya ven nizhney poloviny tulovishcha. Vestnik Sankt-Peterburgskogo universiteta. 2006;11(3):50–61.

9. Champaneria R, Shah L, Moss J, Gupta JK, Birch J, Middleton LJ, Daniels JP. The relationship between pelvic vein incompetence and chronic pelvic pain in women: systematic reviews of diagnosis and treatment effectiveness. Health Technology Assessment. 2016;20(5):1–108.

10. Sharma K, Bora MK, Varghese J, Malik G, Kuruvilla R. Role of Trans Vaginal Ultrasound and Doppler in Diagnosis of Pelvic Congestion Syndrome. J Clinic and Diagnos Research. 2014;8(7):05–07.

11. DOI: 10.7860/JCDR/2014/8106.4570.

12. Durham JD, Machan L. Pelvic Congestion Syndrome. Semin Intervent Radiol. 2013;30:372–380.

13. Ahmed O, Ng J, Patel M, Ward TJ, Wang DS, Shah R, Hofmann LV. Endovascular Stent Placement for May-Thurner Syndrome in the Absence of Acute Deep Vein Thrombosis. J Vasc Interv Radiol. 2016;27(2):167–173. DOI: 10.1016/j.jvir.2015.10.028.

14. Antignani PL, Lazarashvili Z, Monedero JL, Ezpeleta SZ, Whiteley MS, Khilnani NM, Meissner MH, Wittens CH, Kurstjens RL, Belova L, Bokuchava M, Elkashishi WT, Jeanneret-Gris C, Geroulakos G, Gianesini S, de Graaf R, Krzanowski M, Al Tarazi L, Tessari L, Wikkeling M. Diagnosis and treatment of pelvic congestion syndrome: UIP consensus document. Int Angiol. 2019;38(4):265–283.

15. DOI: 10.23736/S0392-9590.19.04237-8.

16. He L, Giri TK, Vicente CP, Tollefsen DM. Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. Blood. 2008;111(8):4118-25. DOI:10.1182/blood-2007-12-127928.

17. Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: valve dysfunction and wall dilation. Phlebology. 2008;23:85–98.

18. Greiner M, Dadon M, Lemasle P, Cluzel P. How does the patho-physiology influence the treatment of pelvic congestion syndrome and is the result long-lasting? Phlebology. 2012;27(1):58–64.